Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Marti

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Plos One|March 10, 2016
Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL)Siddha Kasar, Chingiz Underbayev, Moinuddin Hassan, et al.
British Journal of Haematology|November 21, 2007
Overview of monoclonal B-cell lymphocytosisGerald Marti, Fatima Abbasi, Elizabeth Raveche, et al.
JAMA Dermatology|March 17, 2016
Hair and Nail Changes During Long-term Therapy With Ibrutinib for Chronic Lymphocytic LeukemiaCarole Bitar, Mohammed Z H Farooqui, Janet Valdez, et al.
British Journal of Haematology|November 21, 2007
Chronic lymphocytic leukaemia genetics overviewNeil Caporaso, Lynn Goldin, Christoph Plass, et al.
Cytometry. Part B, Clinical Cytometry|September 15, 2010
The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemiaErica Salerno, Yao Yuan, Brian J Scaglione, et al.
Leukemia & Lymphoma|March 18, 2021
Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphomaJayalakshmi Balakrishna, Neil Basumallik, Robert Matulonis, et al.
Haematologica|May 30, 2013
Rapid clearance of rituximab may contribute to the continued high incidence of autoimmune hematologic complications of chemoimmunotherapy for chronic lymphocytic leukemiaClifton C Mo, Ndegwa Njuguna, Paul V Beum, et al.
Cytometry. Part B, Clinical Cytometry|April 24, 2008
Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemiaEjaz Ahmad, Seth M Steinberg, Lynn Goldin, et al.
JAMA Oncology|September 4, 2015
Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort StudyOla Landgren, Youn K Shim, Joel Michalek, et al.
American Journal of Clinical Pathology|November 15, 2013
Quantification of expression of antigens targeted by antibody-based therapy in chronic lymphocytic leukemiaPrashant R Tembhare, Gerald Marti, Adrian Wiestner, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Plos One|March 10, 2016
Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL)Siddha Kasar, Chingiz Underbayev, Moinuddin Hassan, et al.
British Journal of Haematology|November 21, 2007
Overview of monoclonal B-cell lymphocytosisGerald Marti, Fatima Abbasi, Elizabeth Raveche, et al.
JAMA Dermatology|March 17, 2016
Hair and Nail Changes During Long-term Therapy With Ibrutinib for Chronic Lymphocytic LeukemiaCarole Bitar, Mohammed Z H Farooqui, Janet Valdez, et al.
British Journal of Haematology|November 21, 2007
Chronic lymphocytic leukaemia genetics overviewNeil Caporaso, Lynn Goldin, Christoph Plass, et al.
Cytometry. Part B, Clinical Cytometry|September 15, 2010
The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemiaErica Salerno, Yao Yuan, Brian J Scaglione, et al.
Leukemia & Lymphoma|March 18, 2021
Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphomaJayalakshmi Balakrishna, Neil Basumallik, Robert Matulonis, et al.
Haematologica|May 30, 2013
Rapid clearance of rituximab may contribute to the continued high incidence of autoimmune hematologic complications of chemoimmunotherapy for chronic lymphocytic leukemiaClifton C Mo, Ndegwa Njuguna, Paul V Beum, et al.
Cytometry. Part B, Clinical Cytometry|April 24, 2008
Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemiaEjaz Ahmad, Seth M Steinberg, Lynn Goldin, et al.
JAMA Oncology|September 4, 2015
Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort StudyOla Landgren, Youn K Shim, Joel Michalek, et al.
American Journal of Clinical Pathology|November 15, 2013
Quantification of expression of antigens targeted by antibody-based therapy in chronic lymphocytic leukemiaPrashant R Tembhare, Gerald Marti, Adrian Wiestner, et al.
Pageof 3